Regenosine is developing first-in-class therapies for tissue regeneration. The purinergic system regulates and maintains tissue homeostasis. They have demonstrated that restoring adenosine levels in various
We invest in the most promising early-stage, rapid-growth technology companies in the Mid-Atlantic region.
The Fund typically initially invests $500,000 to $3M, with up to $4-5M to support the company’s growth. The general partners are active investors. Companies benefit from the Fund’s introductions to customers, recruits, resellers, distributors, Board directors, investors, and service providers.